Endogenous testosterone levels and cardiovascular disease in healthy men

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Heart

• Publication date

  2011-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/hrt.2010.217414PMID 21303797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis

  2010cited by this paper
• Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79.

  2010cited by this paper
• Adverse events associated with testosterone administration.

  2010cited by this paper
• Low serum testosterone and increased mortality in men with coronary heart disease

  2010cited by this paper
• Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.

  2009cited by this paper
• Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men.

  2009cited by this paper
• Letter by Pascual-Figal et al regarding article, "Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival".

  2007cited by this paper
• Physiological Testosterone Replacement Therapy Attenuates Fatty Streak Formation and Improves High-Density Lipoprotein Cholesterol in the Tfm Mouse: An Effect That Is Independent of the Classic Androgen Receptor

  2007cited by this paper
• Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.

  2007cited by this paper
• Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival

  2006cited by this paper
• Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.

  2006cited by this paper
• Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction.

  2006cited by this paper
• Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.

  2006cited by this paper
• Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.

  2006cited by this paper
• Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

  2006cited by this paper
• Hypogonadism and metabolic syndrome: implications for testosterone therapy.

  2005cited by this paper
• Increased carotid atherosclerosis in andropausal middle-aged men.

  2005cited by this paper
• Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life

  2004cited by this paper
• Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men

  2004cited by this paper
• Testosterone is a potent inhibitor of L-type Ca(2+) channels.

  2004cited by this paper
• Acute haemodynamic effects of testosterone in men with chronic heart failure.

  2003cited by this paper
• Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study.

  2002cited by this paper
• Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.

  2001cited by this paper
• Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

  2001cited by this paper
• [Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. A randomized, double-blind, placebo-controlled study].

  2001cited by this paper
• Chronic Stable Angina : A Randomized , Double-Blind , Placebo-Controlled Study Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With

  2000cited by this paper
• Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms.

  2000cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper

• Major cardiovascular disease risk in men with testosterone deficiency (hypogonadism): appraisal of short, medium and long-term testosterone therapy - a narrative review.

  2023cites this paper
• Relation of Testosterone Normalization to Mortality and Myocardial Infarction in Men With Previous Myocardial Infarction.

  2019cites this paper
• Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial

  2018cites this paper
• Effect of Degarelix, a Gonadotropin-Releasing Hormone Receptor Antagonist for the Treatment of Prostate Cancer, on Cardiac Repolarisation in a Randomised, Placebo and Active Comparator Controlled Thorough QT/QTc Trial in Healthy Men

  2017cites this paper
• Androgen Therapy and Rehospitalization in Older Men With Testosterone Deficiency.

  2016cites this paper
• Low-dose testosterone protects against renal ischemia-reperfusion injury by increasing renal IL-10-to-TNF-α ratio and attenuating T-cell infiltration.

  2016cites this paper
• Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men.

  2015cites this paper
• Risk of Myocardial Infarction in Older Men Receiving Testosterone Therapy

  2014cites this paper
• The effect of serum free testosterone level on glycemic control and atherosclerosis in type 2 diabetic men

  2014cites this paper
• The influence of gender and sex hormones in the development of translational and experimental pulmonary arterial hypertension

  2014cites this paper
• Testosterone Replacement Therapy Improves QTaVI in Hypogonadal Men with Spinal Cord Injury

  2013cites this paper
• Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?

  2012cites this paper